S304: SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, PROVIDES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2 YEAR FOLLOW-UP FROM THE CARDINAL STUDY

Bibliographic Details
Main Authors:	A. Röth, C. M. Broome, W. Barcellini, T. Henrik Anderson Tvedt, Y. Miyakawa, S. D’Sa, D. Cella, F. Joly, J. Wang, T. Sourdille, F. Shafer, M. Wardęcki, I. C. Weitz
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000844108.70297.06

Internet